Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration

Cardiovascular disease is still one of the leading causes of death in the world, and heart transplantation is the current major treatment for end-stage cardiovascular diseases. However, because of the shortage of heart donors, new sources of cardiac regenerative medicine are greatly needed. The prom...

Full description

Bibliographic Details
Main Authors: Nanbo Liu, Xing Ye, Bin Yao, Mingyi Zhao, Peng Wu, Guihuan Liu, Donglin Zhuang, Haodong Jiang, Xiaowei Chen, Yinru He, Sha Huang, Ping Zhu
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2021-05-01
Series:Bioactive Materials
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2452199X20302735
id doaj-2a01c2602eb8404ebc5f272512f81825
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Nanbo Liu
Xing Ye
Bin Yao
Mingyi Zhao
Peng Wu
Guihuan Liu
Donglin Zhuang
Haodong Jiang
Xiaowei Chen
Yinru He
Sha Huang
Ping Zhu
spellingShingle Nanbo Liu
Xing Ye
Bin Yao
Mingyi Zhao
Peng Wu
Guihuan Liu
Donglin Zhuang
Haodong Jiang
Xiaowei Chen
Yinru He
Sha Huang
Ping Zhu
Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration
Bioactive Materials
3D bioprinting
Stem cell therapy
Bioink
Heart repair and regeneration
author_facet Nanbo Liu
Xing Ye
Bin Yao
Mingyi Zhao
Peng Wu
Guihuan Liu
Donglin Zhuang
Haodong Jiang
Xiaowei Chen
Yinru He
Sha Huang
Ping Zhu
author_sort Nanbo Liu
title Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration
title_short Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration
title_full Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration
title_fullStr Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration
title_full_unstemmed Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration
title_sort advances in 3d bioprinting technology for cardiac tissue engineering and regeneration
publisher KeAi Communications Co., Ltd.
series Bioactive Materials
issn 2452-199X
publishDate 2021-05-01
description Cardiovascular disease is still one of the leading causes of death in the world, and heart transplantation is the current major treatment for end-stage cardiovascular diseases. However, because of the shortage of heart donors, new sources of cardiac regenerative medicine are greatly needed. The prominent development of tissue engineering using bioactive materials has creatively laid a direct promising foundation. Whereas, how to precisely pattern a cardiac structure with complete biological function still requires technological breakthroughs. Recently, the emerging three-dimensional (3D) bioprinting technology for tissue engineering has shown great advantages in generating micro-scale cardiac tissues, which has established its impressive potential as a novel foundation for cardiovascular regeneration. Whether 3D bioprinted hearts can replace traditional heart transplantation as a novel strategy for treating cardiovascular diseases in the future is a frontier issue. In this review article, we emphasize the current knowledge and future perspectives regarding available bioinks, bioprinting strategies and the latest outcome progress in cardiac 3D bioprinting to move this promising medical approach towards potential clinical implementation.
topic 3D bioprinting
Stem cell therapy
Bioink
Heart repair and regeneration
url http://www.sciencedirect.com/science/article/pii/S2452199X20302735
work_keys_str_mv AT nanboliu advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration
AT xingye advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration
AT binyao advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration
AT mingyizhao advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration
AT pengwu advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration
AT guihuanliu advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration
AT donglinzhuang advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration
AT haodongjiang advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration
AT xiaoweichen advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration
AT yinruhe advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration
AT shahuang advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration
AT pingzhu advancesin3dbioprintingtechnologyforcardiactissueengineeringandregeneration
_version_ 1724252160691011584
spelling doaj-2a01c2602eb8404ebc5f272512f818252021-02-25T04:19:35ZengKeAi Communications Co., Ltd.Bioactive Materials2452-199X2021-05-016513881401Advances in 3D bioprinting technology for cardiac tissue engineering and regenerationNanbo Liu0Xing Ye1Bin Yao2Mingyi Zhao3Peng Wu4Guihuan Liu5Donglin Zhuang6Haodong Jiang7Xiaowei Chen8Yinru He9Sha Huang10Ping Zhu11Department of Cardiac Surgery, and Department of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510100, ChinaDepartment of Cardiac Surgery, and Department of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510100, China; Department of Cardiac Surgery, Affiliated South China Hospital, Southern Medical University (Guangdong Provincial People's Hospital) and The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, 510515, ChinaResearch Center for Tissue Repair and Regeneration affiliated to the Medical Innovation Research Department, PLA General Hospital and PLA Medical College, 28 Fu Xing Road, Beijing, 100853, ChinaDepartment of Cardiac Surgery, and Department of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510100, ChinaDepartment of Cardiac Surgery, and Department of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510100, China; Department of Cardiac Surgery, Affiliated South China Hospital, Southern Medical University (Guangdong Provincial People's Hospital) and The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, 510515, ChinaDepartment of Cardiac Surgery, and Department of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510100, China; School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510006, ChinaDepartment of Cardiac Surgery, and Department of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510100, ChinaDepartment of Cardiac Surgery, and Department of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510100, China; School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510006, ChinaDepartment of Cardiac Surgery, and Department of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510100, ChinaDepartment of Cardiac Surgery, and Department of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510100, ChinaResearch Center for Tissue Repair and Regeneration affiliated to the Medical Innovation Research Department, PLA General Hospital and PLA Medical College, 28 Fu Xing Road, Beijing, 100853, China; Corresponding author.Department of Cardiac Surgery, and Department of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510100, China; Department of Cardiac Surgery, Affiliated South China Hospital, Southern Medical University (Guangdong Provincial People's Hospital) and The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, 510515, China; School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510006, China; Corresponding author. Department of Cardiac Surgery, and Department of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510100, China.Cardiovascular disease is still one of the leading causes of death in the world, and heart transplantation is the current major treatment for end-stage cardiovascular diseases. However, because of the shortage of heart donors, new sources of cardiac regenerative medicine are greatly needed. The prominent development of tissue engineering using bioactive materials has creatively laid a direct promising foundation. Whereas, how to precisely pattern a cardiac structure with complete biological function still requires technological breakthroughs. Recently, the emerging three-dimensional (3D) bioprinting technology for tissue engineering has shown great advantages in generating micro-scale cardiac tissues, which has established its impressive potential as a novel foundation for cardiovascular regeneration. Whether 3D bioprinted hearts can replace traditional heart transplantation as a novel strategy for treating cardiovascular diseases in the future is a frontier issue. In this review article, we emphasize the current knowledge and future perspectives regarding available bioinks, bioprinting strategies and the latest outcome progress in cardiac 3D bioprinting to move this promising medical approach towards potential clinical implementation.http://www.sciencedirect.com/science/article/pii/S2452199X203027353D bioprintingStem cell therapyBioinkHeart repair and regeneration